Related Experiment Video
Updated: May 3, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
18.1K
Second primary mucosal malignant melanoma in hypopharynx.
Sang Gue Kang1, Chul Han Kim, Min Sung Tark
1From the Departments of *Plastic and Reconstructive Surgery, †Otolaryngology-Head and Neck Surgery, and ‡Pathology, Soonchunhyang University College of Medicine, Seoul, Korea.
The Journal of Craniofacial Surgery
|February 12, 2014
Summary
A rare case of a second primary mucosal melanoma in the hypopharynx developed in a patient with prior cutaneous malignant melanoma. This highlights the need for thorough head and neck examinations during follow-up for melanoma patients.
Area of Science:
- Oncology
- Head and Neck Surgery
- Dermatology
Background:
- Primary mucosal melanomas of the head and neck are uncommon.
- Developing a second primary mucosal melanoma after a cutaneous malignant melanoma is exceptionally rare.
Observation:
- A 76-year-old woman with a history of cutaneous malignant melanoma presented with a throat foreign body sensation.
- Endoscopy identified a black mass in the hypopharyngeal piriform sinus, confirmed histopathologically as a second primary mucosal malignant melanoma.
Findings:
- The patient underwent surgical excision and reconstruction.
- Postoperatively, metastasis was diagnosed within five months, with widespread dissemination evident by eight months.
- The patient died nine months after surgery.
Implications:
- This case underscores the critical importance of including detailed hypopharyngeal and head and neck examinations in the surveillance protocols for all patients with a history of cutaneous malignant melanoma.
- Early detection through vigilant follow-up may improve outcomes for rare secondary mucosal melanomas.
More Related Videos
Related Concept Videos
Cellular Adaptation IV: Dysplasia and Metaplasia
49
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
49
Barrett Esophagus-I: Introduction
1.5K
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.5K
Skin Cancer
5.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
Esophageal Achalasia
45
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide...
45

